Back

Egetis Therapeutics to join two September 2026 healthcare conferences

Verifying
  • Egetis Therapeutics will participate in two healthcare investor conferences during September 2026.
  • September 28, 2026, is the FDA target action date for Emcitate’s U.S. application.
  • Nicklas Westerholm will represent Egetis in fireside chats and one-on-one investor meetings.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.